ORG Wealth Partners’s Relay Therapeutics RLAY Stock Holding History

ORG Wealth Partners’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18	Buy	+1	New	+$19	﹤0.01%	2528

Other funds holding RLAY

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return

ORG Wealth Partners's RLAY Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Relay Therapeutics (RLAY) in Q3 2026: 1 share worth $18. The stake represents ﹤0.01% of the portfolio and ranks #2528 among its holdings.

107 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

ORG Wealth Partners held 1 share of Relay Therapeutics worth $18 as of Q3 2026.
Relay Therapeutics was a new ORG Wealth Partners position in Q3 2026.
Relay Therapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2528 holding.
107 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.